Peng Zhang | Biological Science | Best Researcher Award

Dr. Peng Zhang | Biological Science | Best Researcher Award

Assistant Professor, Tianjin University of Technology, China

Dr. Peng Zhang is an Assistant Professor at the Life and Health Intelligent Research Institute, Tianjin University of Technology. With a strong focus on understanding gut microbiota and its impact on health, Dr. Zhang combines expertise in natural product research with advanced omics technologies. His work explores innovative ways to improve bioavailability and efficacy of therapeutic agents. 🌟

Publication Profile

Strengths for the Award:

  1. Innovative Research Focus: Peng Zhang’s work on natural products, drug delivery systems, and the role of gut microbiota in health demonstrates a high level of innovation and relevance in the field of life and health sciences.
  2. Significant Publications: Zhang has a strong publication record in reputable journals, including Journal of Functional Foods, Journal of Agricultural and Food Chemistry, and The ISME Journal. His research on gut microbiota and its impact on health conditions showcases his expertise and contributions to the field.
  3. Active Projects: Leading national projects funded by the National Natural Science Foundation of China, Zhang’s research includes high-impact topics like antibiotic resistance and its effects on gut microbiota. This aligns with current global health challenges.
  4. Diverse Experience: Zhang’s experience spans from studying the effects of natural products on obesity to the development of nanotechnology-based drug delivery systems, indicating a broad and applied approach to research.

Areas for Improvement:

  1. Broader Impact and Outreach: While Zhang’s research is impactful, expanding efforts to disseminate findings to a wider audience, including the general public and policymakers, could enhance the societal impact of his work.
  2. Collaborations and Networking: Increasing collaborations with international researchers and institutions could further strengthen his research’s global relevance and visibility.
  3. Grant and Project Diversification: Although Zhang has led and participated in significant projects, diversifying funding sources and project scopes might provide additional opportunities for groundbreaking research.

Education

Dr. Zhang earned his PhD from Nankai University, Tianjin, China, in 2021, where he developed models to study the role of gut microbiota in health crises caused by antibiotics. Prior to this, he completed his graduate studies at Hainan University, Haikou, China, focusing on the effects of dietary compounds on obesity. 🎓

Experience

2022 – Present: Assistant Professor, Life and Health Intelligent Research Institute, Tianjin University of Technology, Tianjin, China. Research includes purifying natural products and developing nanotechnology-based drug delivery systems. 🔬2017 – 2021: PhD student, Nankai University, Tianjin, China. Developed models to study antibiotic exposure and drug-resistant bacteria. 🧪2015 – 2017: Graduate student, Hainan University, Haikou, China. Examined effects of Luo Han Guo on obesity. 🌿

Research Focus

Dr. Zhang’s research primarily investigates the role of natural products in alleviating inflammatory diseases and improving gut health. His projects include:

Purifying Natural Products: Studying polysaccharides and polyphenols from medicinal foods to understand their impact on inflammatory diseases and gut microbiota. 🌱Drug Delivery Systems: Developing nanotechnology-based encapsulation systems to enhance the bioavailability of active compounds. 🚀

Awards and Honours

Dr. Zhang’s contributions to the field are recognized through various awards and honors. Notable mentions include his significant contributions to understanding the interactions between gut microbiota and therapeutic agents. 🏅

Publications Top Note

Biological Science, Biological Research, Life Sciences

  1. Polysaccharides isolated from Hibiscus sabdariffa L. mitigate intestinal radiation injury, Journal of Functional Foods, 2024.
  2. Polysaccharide Isolated from Agaricus blazei Murill Alleviates Intestinal Ischemia/Reperfusion Injury, Journal of Agricultural and Food Chemistry, 2024.
  3. The Gut Microbiota Contributes to Systemic Responses and Liver Injury in Gut-Derived Sepsis, Microorganisms, 2023.
  4. Porphyromonas gingivalis exacerbates alcoholic liver disease, Journal of Clinical Periodontology, 2023.
  5. Gut microbiota exaggerates triclosan-induced liver injury, Journal of Hazardous Materials, 2022.

 

Conclusion:

Peng Zhang is a highly qualified candidate for the Research for Best Researcher Award. His innovative research, strong publication record, and leadership in significant projects underscore his contributions to the field. Addressing areas for improvement, such as expanding outreach and fostering international collaborations, could further enhance his impact and recognition in the global research community.

 

Milad Mollaali | Epigeneics | Best Researcher Award

Mr. Milad Mollaali | Epigeneics | Best Researcher Award

Milad Mollaali, University of Sistan and Baluchestan, Iran

Milad Mollaali is a dedicated researcher specializing in genetic epidemiology and molecular biology, focusing on cancer genetics and autoimmune diseases. His work spans several high-impact journals, contributing significantly to the understanding of genetic markers in disease susceptibility.

Profile

Orcid

Education 📚

Milad Mollaali holds a Ph.D. in Molecular Biology , where he specialized in genetic epidemiology and molecular genetics.

Experience 💼

Milad Mollaali has extensive experience in genetic research, particularly in cancer genetics and autoimmune diseases. He has contributed to numerous studies exploring gene expressions and polymorphisms related to various cancers, enhancing the understanding of disease mechanisms.

Awards 🏆

Milad Mollaali has been recognized for his contributions to genetic epidemiology and cancer research, receiving awards for excellence in scientific research and publication.

Research focus

Milad Mollaali’s research primarily focuses on genetic aspects of various cancers prevalent in Iran, particularly oral squamous cell carcinoma (OSCC) and gastric cancer. He investigates gene expressions such as JAK2, STAT3, CTLA4, DRD1, NF-κB, TRAF1, and TRAF2, along with genetic polymorphisms like rs774034163. His studies contribute significantly to understanding the molecular mechanisms underlying cancer development and progression in Iranian populations. 🧬 His work aims to elucidate biomarkers and potential therapeutic targets, offering insights into personalized medicine approaches for cancer management in the region.

Publications Top Notes📄

Association of HLA‐DQ4/5 genotype polymorphisms with celiac disease in a group of children in Southwest Iran: A case‐control study

Reporting an Iranian Female Patient Suffering from Colorectal Cancer with a Missense Mutation in Exon 2 of MEN1 Gene: An Unusual Case

Evaluation of DRD1 Gene Expression Pattern and rs774034163 Genetic Polymorphism in Patients with Gastric Cancer: A Case-Control Study in Iran

Investigation of the NF-κB, TRAF1, and TRAF2 Relative Gene Expressions in a Population of Iranian Patients with Oral Squamous Cell Carcinoma: A Case-Control Study

Assessing the Relationship of C-FOS Gene Expression and rs997415225 Polymorphism with Gastric Cancer in the Iranian Population of Isfahan Province

Studying the Association of Gene Expressions and Gene Polymorphisms of MAPK14 rs28763973) and HTR2B rs550352538) with Gastric Cancer in Isfahan Province